Young Hoon Youn Selected Research

Hemorrhage

2/2024	The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.
1/2018	Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Hoon Youn Research Topics

Disease

12	Esophageal Achalasia (Megaesophagus) 09/2023 - 02/2014
11	Neoplasms (Cancer) 01/2023 - 10/2004
10	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2006
8	Gastroesophageal Reflux (GERD) 02/2024 - 10/2013
4	Dyspepsia (Indigestion) 05/2024 - 01/2015
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2015
3	Ulcer 02/2024 - 01/2016
3	Pain (Aches) 01/2024 - 12/2015
3	Carcinogenesis 03/2022 - 01/2022
3	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2014
3	Deglutition Disorders (Dysphagia) 01/2015 - 04/2013
2	Hemorrhage 02/2024 - 01/2018
2	Peptic Ulcer (Peptic Ulcers) 02/2024 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2022
2	Rheumatoid Arthritis 01/2022 - 10/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 10/2015
2	Crohn Disease (Crohn's Disease) 01/2022 - 10/2015
2	Eosinophilic Esophagitis 06/2021 - 07/2018
2	Gastric Outlet Obstruction 05/2020 - 01/2013
2	Heartburn (Pyrosis) 11/2019 - 07/2017
2	Adenocarcinoma 01/2019 - 12/2007
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 11/2015
2	Peritoneal Neoplasms 12/2018 - 06/2018
2	Eosinophilia 07/2018 - 04/2013
2	Infections 06/2018 - 07/2016
2	Esophageal Motility Disorders (Nutcracker Esophagus) 01/2016 - 01/2014
2	Thrombosis (Thrombus) 10/2004 - 03/2002
2	Hepatocellular Carcinoma (Hepatoma) 10/2004 - 03/2002
1	Esophagitis 10/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2023
1	Non-Erosive Reflux Disease 10/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Pleural Effusion (Pleural Effusions) 04/2022
1	Fever (Fevers) 04/2022
1	Emphysema 04/2022
1	Subcutaneous Emphysema 04/2022
1	Pneumonia (Pneumonitis) 04/2022
1	Precancerous Conditions 01/2022
1	Metaplasia 01/2022
1	Atrophic Gastritis 01/2022
1	Ankylosing Spondylitis 01/2022
1	Ulcerative Colitis 01/2022
1	Ileus 10/2021
1	Peptic Esophagitis (Reflux Esophagitis) 11/2019
1	Sarcopenia 01/2019
1	Carcinoma (Carcinomatosis) 12/2018
1	Neoplasm Metastasis (Metastasis) 11/2016
1	Bacillary Dysentery (Shigellosis) 07/2016
1	Muscle Spasticity (Spastic) 01/2016
1	Cicatrix (Scar) 01/2016

Drug/Important Bio-Agent (IBA)

12	Proton Pump InhibitorsIBA 05/2024 - 04/2013
5	Triglycerides (Triacylglycerol)IBA 12/2022 - 01/2017
4	AcidsIBA 05/2024 - 10/2015
4	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2022
3	mosaprideIBA 01/2024 - 10/2013
3	ORALIT (ORS)IBA 12/2022 - 04/2015
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2018
2	tegoprazanIBA 05/2024 - 02/2024
2	BariumIBA 09/2023 - 08/2015
2	Immunomodulating AgentsIBA 01/2023 - 01/2022
2	Long Noncoding RNAIBA 01/2019 - 11/2016
2	Lactulose (Duphalac)FDA LinkGeneric 07/2011 - 10/2010
1	Esomeprazole (Nexium)FDA Link 02/2024
1	PotassiumIBA 02/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024
1	Nortriptyline (Aventyl)FDA LinkGeneric 01/2024
1	WD repeat containing planar cell polarity effectorIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 05/2022
1	ParaffinIBA 05/2022
1	Formaldehyde (Formol)FDA Link 05/2022
1	C-Reactive ProteinIBA 10/2021
1	Rabeprazole (Aciphex)FDA Link 01/2021
1	rebamipideIBA 01/2021
1	polaprezinc (Z 103)IBA 01/2021
1	Pantoprazole (Protonix)FDA LinkGeneric 01/2021
1	AlginatesIBA 11/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2019
1	vasectrin IIIIBA 07/2019
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 06/2018
1	HDL LipoproteinsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 07/2016
1	antineoplaston A10 (A 10)IBA 01/2016

Therapy/Procedure

7	Myotomy 04/2022 - 01/2016
5	Therapeutics 10/2023 - 10/2015
4	Aftercare (After-Treatment) 06/2021 - 04/2013
4	Stents 05/2020 - 01/2013
3	Drug Therapy (Chemotherapy) 05/2022 - 10/2004
3	Chemoradiotherapy 03/2021 - 01/2014
3	Self Expandable Metallic Stents 05/2020 - 01/2013
3	Radiotherapy 01/2019 - 03/2002
2	Length of Stay 04/2022 - 10/2021
2	Gastrectomy 10/2021 - 03/2014
1	Heller Myotomy 07/2019
1	Endoscopic Hemostasis 01/2018